doTERRA is pleased to announce the appointment of Dr. Russell J. Osguthorpe, M.D. as its new Chief Medical Officer and Vice President of medical and scientific initiatives. Dr. Osguthorpe is an experienced medical executive trained in Pediatric Infectious Diseases, who comes to doTERRA from Intermountain Healthcare.
"Since doTERRA was established a little more than a decade ago, I have been honored to serve as Chief Medical Officer and Chairman of the Scientific Advisory Committee," said Dr. David Hill. "Through unprecedented global growth and the awakening of the world to the role of essential oils in modern medicine, the time has come to expand our medical initiative. As such, we are thrilled to welcome Dr. Russell Osguthorpe as doTERRA's new Chief Medical Officer."
"Dr. Osguthorpe will focus on doTERRA's growing medical integration initiative and strengthening doTERRA's professional relationships with hospitals, medical clinics, and universities, while expanding our research programs," said doTERRA founding executive and CEO, David Stirling. "Dr. Hill will not only continue to chair the Scientific Advisory Committee and tirelessly educate the world about essential oils, he also will serve as chair of the newly established Medical Executive Committee. As the world's foremost expert on essential oils, Dr. Hill will enjoy even more capacity to expand our understanding of essential oils and their use in modern health practices."
Prior to joining doTERRA, Dr. Osguthorpe was the Pediatric Medical Director and Pediatric Department Chair of a tertiary care hospital. For twenty years, Dr. Osguthorpe has been committed to providing patients high quality healthcare in a manner that is both compassionate and safe. He has established large multispecialty practices in many disciplines and has a wealth of expertise in leading change through teaming.
"I came to doTERRA so that I could promote an environment where patients are empowered and feel that the whole person is being treated and not just their symptoms," said Dr. Osguthorpe. "I believe that doTERRA is in a position to disrupt the healthcare system in innovative and positive ways that will allow people the greatest freedom and opportunity to dramatically improve their family's health. I am excited to embark on the new and exciting changes ahead and look forward to working with Dr. Hill and doTERRA's excellent team to make this change a reality."
As CMO, Dr. Osguthorpe will report to Dave Stirling and Dr. Hill and lead doTERRA's healthcare and research teams. His direct reports include Dr. Brannick Riggs, M.D., Nicole Stevens MS, and Cody Beaumont, Ph.D. Dr. Riggs, doTERRA's VP of Healthcare Initiatives, will serve as the Senior Medical Director of doTERRA's Pleasant Grove Prime Meridian Medical Complex, which will open in April of 2019. Riggs will also lead doTERRA's medical advisory board and doTERRA's clinic development team. Stevens, a Ph.D. candidate and doTERRA's Director of Essential Oil and Clinical Research, is a trained laboratory scientist, specializing in essential oils. Nicole will oversee formulations, informational research, and clinical trials involving essential oils, clarifying their chemistry and physiological activity in humans. Beaumont, doTERRA's Sr. Director of Quality Control, has a Ph.D. in Medicinal Chemistry and is an experienced scientific director in the health-wellness and fitness industry. Cody is also skilled in pharmacokinetics, method development, pharmaceutical research, LCMS, GCMS, XRF, ICP, and technical writing.